GF-1005

N/A

Report date: 2025/05/16 17:35:42

Base Information

Drug NameGF-1005
Drug Alias NameGF-1005
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-6 modulators
TargetsNAD-dependent protein deacetylase sirtuin-6
Therapy Area/IndicationsSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenflow Biosciences PLC
China Registration ClassN/A

Develop Information

Active CompaniesGenflow Biosciences PLC
Inactive CompaniesN/A
Active IndicationsSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A